Dicerna Pharmaceuticals Announces Appointment Of Biotech Industry Leader Bruce Peacock To Its Board Of Directors And Audit Committee

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, announced today the appointment of Bruce Peacock to its board of directors and audit committee. Mr. Peacock currently serves as chief financial and business officer at Ophthotech Corporation.

“Bruce Peacock is a recognized leader in the biotech industry,” stated the company’s chief executive officer, Dr. Douglas Fambrough. “With an impressive list of accomplishments in operations, management and business development, Bruce will be a terrific addition to our board.”

Help employers find you! Check out all the jobs and post your resume.

Back to news